Advertisement

Topics

"Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medication Database: Page 4

23:23 EDT 20th March 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" on BioPortfolio

We have published hundreds of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma news stories on BioPortfolio along with dozens of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Clinical Trials and PubMed Articles about Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Companies in our database. You can also find out about relevant Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Drugs and Medications on this site too.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Drugs and Medications 76–93 of 93

Possibly Relevant

Acyclovir [g&w laboratories, inc.]

Acyclovir Ointment USP 5% For Topical Dermatologic Use Only Not for Ophthalmic, Oral or Intravaginal Use Rx Only

Acyclovir [actavis pharma, inc.]

Acyclovir Ointment 5%

Sovaldi [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. SOVALDI(sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Acyclovir [northstar rx llc]

Acyclovir Ointment, USP 5%

Acyclovir [alembic pharmaceuticals inc.]

Acyclovir Ointment USP, 5%

Acyclovir [alembic pharmaceuticals limited]

Acyclovir Ointment USP, 5%

Acyclovir [amneal pharmaceuticals of new york, llc]

Acyclovir Ointment, USP 5%

Zovirax [valeant pharmaceuticals north america llc]

PRESCRIBING INFORMATION ZOVIRAX® (acyclovir) Ointment 5%

Imfinzi [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI (durvalumab) injection, for intravenous useInitial U.S. Approval: 2017

Acyclovir [e. fougera & co. a division of fougera pharmaceuticals inc.]

fougera ACYCLOVIR OINTMENT USP 5%

Istodax [celgene corporation]

These highlights do not include all the information needed to use ISTODAX safely and effectively.  See full prescribing information for ISTODAX. ISTODAX (romidepsin) for injection, for intravenous use Initial U.S. Approval:  2009

Zovirax [rebel distributors corp]

ZOVIRAX (acyclovir) Cream 5%USE ONLY FOR COLD SORES

Sovaldi access [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. GILEAD ACCESS PROGRAM SOVALDI™ (sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Benlysta [human genome sciences, inc.]

These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA.BENLYSTA (belimumab) for injection, for intravenous useBENLYSTA (belimumab) injection, for subcutaneous useIni

Adlyxin [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ADLYXIN safely and effectively. See full prescribing information for ADLYXIN. ADLYXIN (lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 2016

Enbrel [a-s medication solutions]

These highlights do not include all the information needed to use ENBREL safely and effectively. See full prescribing information for ENBREL .     ENBREL (etanercept)   injection , for subcutaneous use ENBREL (etanercept) for injection, for subcutaneo

Enbrel [immunex corporation]

These highlights do not include all the information needed to use ENBREL safely and effectively. See full prescribing information for ENBREL .     ENBREL (etanercept)   injection , for subcutaneous use ENBREL (etanercept) for injection, for subcutaneo

Empliciti [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use EMPLICITI safely and effectively. See full prescribing information for EMPLICITI. EMPLICITI (elotuzumab) for injection, for intravenous useInitial U.S. Approval: 2015



Advertisement
Quick Search
Advertisement
Advertisement